Company intelligence / Profile preview

MeamoShop

Prague, Czech Republic

Ownership: Private
Development stage: Other

Overview

Meamo is a health-tech company focused on personalized nutrition and longevity through the integration of genetic testing and customized supplementation. The company offers DNA analysis kits that evaluate various genetic markers related to metabolism, nutrient absorption, and lifestyle factors. Using this data, Meamo provides tailored nutritional recommendations and bespoke supplement formulations designed to optimize individual health outcomes. Their approach combines nutrigenomics with high-quality ingredients to support long-term wellness and preventive care. The company operates primarily through its digital platform, allowing users to track their health data and receive ongoing nutritional support.

Therapeutic areas: OtherMetabolic Disorders
Modalities: NutraceuticalsDNA testing
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on MeamoShop.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MeamoShop.

Explore the full profile